Artículo

Insulin resistance and polycystic ovary syndrome through life

Diamanti Kandarakis, Evanthia; Spritzer, Poli Mara; Sir Petermann, Teresa; Motta, Alicia BeatrizIcon
Fecha de publicación: 07/2012
Editorial: Bentham Science Publishers
Revista: Current Pharmaceutical Design.
ISSN: 1381-6128
e-ISSN: 1873-4286
Idioma: Inglés
Tipo de recurso: Artículo publicado
Clasificación temática:

Resumen

The heterogeneity of Polycystic Ovary Syndrome (PCOS) emphasizes the need for a consensual review of the data concerning its diagnosis and treatment and for determination of the relationship between the development of PCOS and the ethnic origin, the social status and the lifespan. Insulin resistance is an important characteristic in women with PCOS that aggravates features of PCOS. This review is focused in the diagnosis and treatment of insulin resistance and the risk factors for PCOS during childhood, adolescence and postmenopause. The role of endocrine disruptors and/or their interaction with PCOS have also been analyzed.
Palabras clave: Polycystic Ovary Syndrome , Insulin Resistance , Child , Adolescence , Menopause , Treatments , Diagnosis , Endocrine , Risk Factors , Testosterone
 
Archivos asociados
Thumbnail
 
Tamaño: 225.5Kb
Formato: PDF
.
Licencia
info:eu-repo/semantics/openAccess Excepto donde se diga explícitamente, este item se publica bajo la siguiente descripción: Creative Commons Attribution-NonCommercial-ShareAlike 2.5 Unported (CC BY-NC-SA 2.5)
Identificadores
URI: http://hdl.handle.net/11336/17237
URL: http://www.eurekaselect.com/103435/article
DOI: http://dx.doi.org/10.2174/138161212803307590
Colecciones
Articulos(CEFYBO)
Articulos de CENTRO DE ESTUDIOS FARMACOLOGICOS Y BOTANICOS
Citación
Diamanti Kandarakis, Evanthia; Spritzer, Poli Mara; Sir Petermann, Teresa; Motta, Alicia Beatriz; Insulin resistance and polycystic ovary syndrome through life; Bentham Science Publishers; Current Pharmaceutical Design.; 18; 34; 7-2012; 5569-5576
Compartir
Altmétricas